Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis.
Neil C BinkleyE OrwollRoland D ChapurlatBente Lomholt LangdahlScott D BoydH GiezekA C SantoraPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2020)
Clinicaltrials.gov NCT01120600 (registered May 11, 2010).